Does the integration of genetic (AF PRS) and biomarker (cystatin C) information improve the prediction of sick sinus syndrome incidence compared to sociodemographic and clinical risk factors alone?
Integrating genetic (AF PRS) and biomarker (cystatin C) information modestly improves the prediction of sick sinus syndrome incidence.
In addition to sociodemographic and clinical risk factors, AF PRS and cystatin C were linked to the SSS incidence. Although their inclusion modestly improved prediction, these findings highlighted the potential of integrating genetic and biomarker information for comprehensive SSS risk assessments.
Kim et al. (Wed,) studied this question.